Skip to content

A comparative study between daruharidradi taila and karanja taila in the management of garbhini kikkisa w.s.r. to striae gravidarum

A CLINICAL COMPARATIVE STUDY TO EVALUATE THE EFFECT OF DARUHARIDRADI TAILA AND KARANJA TAILA IN THE MANAGEMENT OF GARBHINI KIKKISA W S R TO STRIAE GRAVIDARUM - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/077491
Enrollment
40
Registered
2024-11-29
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L99- Other disorders of skin and subcutaneous tissue in diseases classified elsewhere

Interventions

None listed

Sponsors

Dr Trupti Rajesh Atkale
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Primi gravidae diagnosed with symptoms of garbhini kikkisa 2. 2nd and 3rd trimester of pregnancy 3. Patient willing to sign the consent form

Exclusion criteria

Exclusion criteria: 1. Pregnant women suffering from any other skin disease except stretch mark / all allergic condition 2. Pregnant women with K/C/O DM 3. Multi gravidae

Design outcomes

Primary

MeasureTime frame
Effect of trial drug on improvement in classical symptoms of garbhini kikkisaTimepoint: 30day, 60day, 90day

Secondary

MeasureTime frame
Safety of the trial drug and adverse drug reaction and aggravation in the symptoms of garbhini kikkisaTimepoint: 30day, 60day, 90day

Countries

India

Contacts

Public ContactDr Trupti Rajesh Atkale

sidramappa Danigond Memorial Trusts Ayurvedic Medical College Post Graduation Centre

Chaitanya.rawal5@gmail.com9880976151

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026